composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente

The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.

Saved in:
Bibliographic Details
Main Authors SRIKANTH VENKATRAMAN, AUSTIN CHEN, UNMESH SHAH, MURALI RAJAGOPALAN, DUANE BURNETTE, LINDA BROCKUNIER, SHOUWU MIAO, HUBERT JOSIEN, KAREN MARCANTONIO, YAN XIA, THOMAS BARA, FRANCISCO VELAZQUEZ, MARIAPPAN V. CHELIAH, YONGXIN HAN, CHARLES JAYNE, SANTHOSH NEELAMKAVIL, ZHUYAN GUO, MARTIN CLASBY, PATRICK PINTO, DIPSHIKA BISWAS, SAMUEL CHACKALAMANNIL, SATHESH BHAT, VINCE J. COLANDREA
Format Patent
LanguagePortuguese
Published 05.12.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.
Bibliography:Application Number: BR20151102541